Short-stay IV fluids to prevent pancreatitis after ERCP
Part of Digestive system clinical trials.
This trial tests whether giving extra IV fluids before, during, and after an ERCP procedure can help prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). If you are scheduled for an ERCP, you may be eligible to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are having an ERCP procedure (a test that looks at your bile and pancreatic ducts).
- You do not have severe heart failure, which would make extra fluids unsafe.
- You do not have severe kidney disease (your kidney function is very low).
- You have not had major surgery that changed your stomach or intestine anatomy.
- You are not pregnant, do not have acute or chronic pancreatitis (unless the ERCP is to treat your pancreatic duct), and do not have certain other conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding ice water irrigation to standard rectal indomethacin reduces the risk of inflammation of the pancreas after ERCP, a procedure that examines the bile and pancreatic ducts. It may help prevent a painful complication.
This trial tests whether rinsing the pancreas with cold water during ERCP can reduce the risk of pancreatitis, a common complication. The treatment is added to the standard medicine (indomethacin) to see if it offers extra protection.
This study tests whether a rectal dose of indomethacin (an anti-inflammatory drug) can help prevent complications after an ERCP. It is for people who have already had a sphincterotomy and are having another ERCP to treat bile duct issues.
This study tests if flushing the bile duct opening with ice-cold water during a procedure called ERCP can reduce the chance of developing pancreatitis afterward. The procedure is done to treat bile duct blockages, and this simple step might help prevent a common complication.
This study tests giving indomethacin (a type of anti-inflammatory medicine) through the rectum in different doses to people having an ERCP (a procedure to look at bile and pancreas tubes), aiming to prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). You may join if you are at high risk for this complication and meet the other health requirements.
This study compares indomethacin (an anti-inflammatory medicine) against using a temporary pancreatic stent to prevent pancreatitis after an ERCP procedure. It may help you lower the chance of painful inflammation of the pancreas after ERCP.
Hear when a new Post-ERCP Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.